Dr. Michael B. Raizman, MD

Dr. Raizman practices at Boston Eye Surgery & Laser Center - West in Waltham, Massachusetts.

Dr. Raizman's NPI, 1790775203, was assigned on October 26, 2005. Dr. Raizman graduated from University of Michigan Medical School in 1982. Dr. Raizman holds Massachusetts license 55622.

Dr. Raizman's primary practice is Boston Eye Surgery & Laser Center - West, at 195 West Street, 2nd Floor, Waltham, MA 02451. The practice phone is (781) 768-5590.

Dr. Raizman's primary practice is Boston Eye Surgery & Laser Center - West in Waltham, Massachusetts. Dr. Raizman is also affiliated with Tufts Medical Center. Dmand AI also links Dr. Raizman to 1 more hospital, 2 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Raizman practices, 5 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Raizman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Raizman is licensed in Massachusetts.

CMS data shows 3,018 Medicare services from Dr. Raizman across 16 procedure codes in 2024, for 1,180 Medicare patients. Medicare paid $492,096 for them.

CMS counts 1,180 Medicare patients who saw Dr. Raizman in 2024. The largest group is 75 to 84, with 558 patients. 71% of them have high cholesterol, and 64% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Raizman's median patient age at 72, with 55% women.

In 2024, Dr. Raizman wrote 2,997 Medicare Part D claims for 761 patients. 57% of them were for generic drugs. CMS names the drug for 2,901 of them, across 28 drugs with 11 or more claims each, at $214,090 in total drug cost. In 2023, CMS named 2,246 claims across 21 drugs.

Dr. Raizman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 788 procedures of cataract surgery by Dr. Raizman, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Raizman, published from 2010 to 2022. 2019 was the busiest year, with 4. The most frequent topics are Double-Blind Method, Ophthalmic Solutions and Intraocular Pressure. Dr. Raizman has published most often in Am J Ophthalmol. Dr. Raizman's most frequent co-authors are Terry Kim, MD, Robert David Gross, MBA, MD and Sunir Joshi, MD.

Dmand AI links Dr. Raizman to 1 clinical trial.

CMS Open Payments shows 217 general payments to Dr. Raizman from 29 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 76% of the total. Shire North American Group Inc paid the most, $49,764. It also lists 1 research payment totaling $3,043 in 2022.

Dr. Raizman graduated from University of Michigan Medical School in 1982.